• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭开非酒精性脂肪性肝病(NAFLD)中的线粒体自噬之谜:用于早期诊断和免疫调节作用的六个关键基因

Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.

作者信息

Luo Zhenguo, Yan Shu, Chao Yu, Shen Ming

机构信息

Department of Internal Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.

Department of Gastroenterology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.

出版信息

Heliyon. 2024 Mar 31;10(7):e28935. doi: 10.1016/j.heliyon.2024.e28935. eCollection 2024 Apr 15.

DOI:10.1016/j.heliyon.2024.e28935
PMID:38601640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11004814/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) stands as a predominant chronic liver ailment globally, yet its pathogenesis remains elusive. This study aims to identify Hub mitophagy-related genes (MRGs), and explore the underlying pathological mechanisms through which these hub genes regulate NAFLD.

METHODS

A total of 3 datasets were acquired from the GEO database and integrated to identify differentially expressed genes (DEGs) in NAFLD and perform Gene Set Enrichment Analysis (GSEA). By intersecting DEGs with MRGs, mitophagy-related differentially expressed genes (MRDEGs) were obtained. Then, hub MRGs with diagnostic biomarker capability for NAFLD were screened and a diagnostic prediction model was constructed and assessed using Nomogram, Decision Curve Analysis (DCA), and ROC curves. Functional enrichment analysis was conducted on the identified hub genes to explore their biological significance. Additionally, regulatory networks were constructed using databases. NAFLD was stratified into high and low-risk groups based on the Riskscore from the diagnostic prediction model. Furthermore, single-sample gene set enrichment analysis (ssGSEA) and CIBERSORT algorithms were employed to analyze immune cell infiltration patterns and the relationship between Hub MRGs and immune cells.

RESULTS

The integrated dataset comprised 122 NAFLD samples and 31 control samples. After screening, 18 MRDEGs were identified. Subsequently, six hub MRGs (NR4A1, PPP2R2A, P4HA1, TUBB6, DUSP1, NAMPT) with diagnostic potential were selected through WGCNA, logistic regression, SVM, RF, and LASSO models, all significantly downregulated in NAFLD samples compared to the control group. A diagnostic prediction model based on these six genes demonstrated robust predictive performance. Functional enrichment analysis of the six hub genes revealed involvement in processes such as protein phosphorylation or dephosphorylation. Correlation analysis demonstrated a significant association between hub MRGs and infiltrating immune cells.

CONCLUSION

We identified six hub MRGs in NAFLD and constructed a diagnostic prediction model based on these six genes, applicable for early NAFLD diagnosis. These genes may participate in regulating NAFLD progression through the modulation of mitophagy and immune activation. Our findings may contribute to subsequent clinical and basic research on NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是全球主要的慢性肝病,但发病机制仍不清楚。本研究旨在识别核心线粒体自噬相关基因(MRGs),并探索这些核心基因调控NAFLD的潜在病理机制。

方法

从GEO数据库获取3个数据集并整合,以识别NAFLD中的差异表达基因(DEGs)并进行基因集富集分析(GSEA)。通过将DEGs与MRGs交叉,获得线粒体自噬相关差异表达基因(MRDEGs)。然后,筛选出具有NAFLD诊断生物标志物能力的核心MRGs,并使用列线图、决策曲线分析(DCA)和ROC曲线构建并评估诊断预测模型。对鉴定出的核心基因进行功能富集分析,以探索其生物学意义。此外,使用数据库构建调控网络。根据诊断预测模型的风险评分将NAFLD分为高风险组和低风险组。此外,采用单样本基因集富集分析(ssGSEA)和CIBERSORT算法分析免疫细胞浸润模式以及核心MRGs与免疫细胞之间的关系。

结果

整合数据集包含122个NAFLD样本和31个对照样本。筛选后,鉴定出18个MRDEGs。随后,通过WGCNA、逻辑回归、支持向量机、随机森林和LASSO模型选择了6个具有诊断潜力的核心MRGs(NR4A1、PPP2R2A、P4HA1、TUBB6、DUSP1、NAMPT),与对照组相比,在NAFLD样本中均显著下调。基于这6个基因的诊断预测模型显示出强大的预测性能。对这6个核心基因的功能富集分析表明它们参与蛋白质磷酸化或去磷酸化等过程。相关性分析表明核心MRGs与浸润免疫细胞之间存在显著关联。

结论

我们在NAFLD中鉴定出6个核心MRGs,并基于这6个基因构建了诊断预测模型,适用于NAFLD的早期诊断。这些基因可能通过调节线粒体自噬和免疫激活参与调控NAFLD进展。我们的研究结果可能有助于后续NAFLD的临床和基础研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/4e40f2d74815/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/7fad957c965a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/9be4b6488185/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/7021e8b65425/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/f64f6947436a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/8871ce3cdd45/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/5513e4c6e694/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/b484513cb311/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/106bfd219d97/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/0fce34ba0455/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/90b2f2196e0b/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/034eba982747/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/4e40f2d74815/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/7fad957c965a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/9be4b6488185/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/7021e8b65425/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/f64f6947436a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/8871ce3cdd45/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/5513e4c6e694/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/b484513cb311/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/106bfd219d97/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/0fce34ba0455/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/90b2f2196e0b/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/034eba982747/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc86/11004814/4e40f2d74815/gr12.jpg

相似文献

1
Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.揭开非酒精性脂肪性肝病(NAFLD)中的线粒体自噬之谜:用于早期诊断和免疫调节作用的六个关键基因
Heliyon. 2024 Mar 31;10(7):e28935. doi: 10.1016/j.heliyon.2024.e28935. eCollection 2024 Apr 15.
2
Identification of novel mitophagy-related biomarkers for Kawasaki disease by integrated bioinformatics and machine-learning algorithms.通过综合生物信息学和机器学习算法鉴定川崎病新的线粒体自噬相关生物标志物。
Transl Pediatr. 2024 Aug 31;13(8):1439-1456. doi: 10.21037/tp-24-230. Epub 2024 Aug 26.
3
Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.基于机器学习和加权基因共表达网络分析的整合分析确定非酒精性脂肪性肝病的氧化应激生物标志物。
Front Immunol. 2024 Feb 27;15:1335112. doi: 10.3389/fimmu.2024.1335112. eCollection 2024.
4
Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的非酒精性脂肪性肝病(NAFLD)合并慢性肾脏病(CKD)诊断生物标志物的鉴定。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1125829. doi: 10.3389/fendo.2023.1125829. eCollection 2023.
5
Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy.鉴定 ULK1 为糖尿病肾病中一种新型的线粒体自噬相关基因。
Front Endocrinol (Lausanne). 2023 Jan 18;13:1079465. doi: 10.3389/fendo.2022.1079465. eCollection 2022.
6
Decoding the mitochondrial connection: development and validation of biomarkers for classifying and treating systemic lupus erythematosus through bioinformatics and machine learning.解码线粒体关联:通过生物信息学和机器学习开发及验证用于系统性红斑狼疮分类与治疗的生物标志物
BMC Rheumatol. 2023 Dec 4;7(1):44. doi: 10.1186/s41927-023-00369-0.
7
Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.基于铜死亡相关基因的生物信息学分析和机器学习鉴定和验证非酒精性脂肪性肝病的潜在诊断标志物和免疫细胞浸润。
Front Immunol. 2023 Sep 26;14:1251750. doi: 10.3389/fimmu.2023.1251750. eCollection 2023.
8
Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.鉴定和验证 INHBE 和 P4HA1 作为非酒精性脂肪性肝病的枢纽基因。
Biochem Biophys Res Commun. 2023 Dec 17;686:149180. doi: 10.1016/j.bbrc.2023.149180. Epub 2023 Oct 30.
9
Machine learning deciphers the significance of mitochondrial regulators on the diagnosis and subtype classification in non-alcoholic fatty liver disease.机器学习解读线粒体调节因子在非酒精性脂肪性肝病诊断和亚型分类中的意义。
Heliyon. 2024 Apr 23;10(9):e29860. doi: 10.1016/j.heliyon.2024.e29860. eCollection 2024 May 15.
10
Bioinformatic Analysis of Key Biomarkers and Infiltrating Immune Cells in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病关键生物标志物和浸润免疫细胞的生物信息学分析。
Altern Ther Health Med. 2024 Jun;30(6):276-283.

引用本文的文献

1
Orphan Nuclear Receptors in Metabolic Dysfunction-associated Steatotic Liver Disease Development.代谢功能障碍相关脂肪性肝病发生过程中的孤儿核受体
J Clin Transl Hepatol. 2025 Aug 28;13(8):682-692. doi: 10.14218/JCTH.2025.00019. Epub 2025 Jun 19.
2
ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet.ASS1是一个枢纽基因,也是通过碳水化合物限制饮食调节代谢功能障碍相关脂肪性肝病的潜在治疗靶点。
Mol Divers. 2025 Apr 17. doi: 10.1007/s11030-025-11187-6.
3
Autophagy: a double-edged sword in ischemia-reperfusion injury.

本文引用的文献

1
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中双向免疫交叉对话。
Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009.
2
Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.鉴定和验证 INHBE 和 P4HA1 作为非酒精性脂肪性肝病的枢纽基因。
Biochem Biophys Res Commun. 2023 Dec 17;686:149180. doi: 10.1016/j.bbrc.2023.149180. Epub 2023 Oct 30.
3
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases.
自噬:缺血再灌注损伤中的双刃剑
Cell Mol Biol Lett. 2025 Apr 7;30(1):42. doi: 10.1186/s11658-025-00713-x.
慢性肝病发生发展中与线粒体功能障碍相关的机制
Biology (Basel). 2023 Oct 5;12(10):1311. doi: 10.3390/biology12101311.
4
Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer.镉通过抑制细胞间线粒体转移促进非酒精性脂肪性肝病。
Cell Mol Biol Lett. 2023 Oct 27;28(1):87. doi: 10.1186/s11658-023-00498-x.
5
Corn peptides attenuate non-alcoholic fatty liver disease via PINK1/Parkin-mediated mitochondrial autophagy.玉米肽通过PINK1/Parkin介导的线粒体自噬减轻非酒精性脂肪性肝病。
Food Nutr Res. 2023 Sep 29;67. doi: 10.29219/fnr.v67.9547. eCollection 2023.
6
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.非酒精性脂肪性肝病:免疫机制与现行治疗方法。
World J Gastroenterol. 2023 Aug 28;29(32):4831-4850. doi: 10.3748/wjg.v29.i32.4831.
7
Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.鉴定与非酒精性脂肪性肝病相关的代谢生物标志物。
Lipids Health Dis. 2023 Sep 11;22(1):150. doi: 10.1186/s12944-023-01911-2.
8
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD.当前针对非酒精性脂肪性肝病脂代谢的治疗方法。
Int J Mol Sci. 2023 Aug 13;24(16):12748. doi: 10.3390/ijms241612748.
9
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy.线粒体代谢功能障碍与非酒精性脂肪性肝病:从发病机制到临床靶向治疗的新见解。
J Transl Med. 2023 Jul 28;21(1):510. doi: 10.1186/s12967-023-04367-1.
10
Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy.槲皮素通过促进AMPK介导的肝脏线粒体自噬改善非酒精性脂肪性肝病(NAFLD)。
J Nutr Biochem. 2023 Oct;120:109414. doi: 10.1016/j.jnutbio.2023.109414. Epub 2023 Jul 7.